Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Enzyme Replacement Therapy Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

This public procurement record has 1 release in its history.

Award

15 Aug 2024 at 01:00

OJEU - F3 - Contract Award Notice
Summary of the contracting process

The Common Services Agency, more commonly known as NHS National Services Scotland (NSS), has completed a procurement process for the supply of Enzyme Replacement Therapy Medicines. The procurement falls under the Health industry category and is to be delivered to all entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014. The awarded contract, valued at £6,079,596, is under a limited procurement method without prior publication of a call for competition, owing to the exclusive rights of the medicines involved. The contract, which was signed on 19 July 2024, follows a streamlined process due to legal regulations protecting intellectual property rights.

This tender represents a significant opportunity for suppliers specialising in pharmaceutical products, particularly those with expertise in Enzyme Replacement Therapy Medicines. Businesses capable of meeting stringent regulatory requirements and those that hold exclusive rights to such specialised medicines are particularly well-suited to this type of procurement. The awarded contract, secured by Takeda UK Limited, showcases an environment where high-value contracts can drive significant business growth within the healthcare and pharmaceutical sectors, especially for companies that can align closely with the specific needs and legal frameworks governing such specialised goods.

How relevant is this notice?

Notice Information

Notice Title

Enzyme Replacement Therapy Medicines

Notice Description

Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland: - NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV(r)) - NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase(r)) - NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal(r))

Lot Information

Lot 1

The Framework Agreement is for the supply of Enzyme Replacement Therapy Medicines (e-g: VPRIV(r)/ Elaprase(r)/ Replagal(r)) to NHS Scotland. The Authority has awarded this framework as a Single supplier framework agreement to one (1) Framework Participant.

Procurement Information

The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000774980
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG512134
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£6,079,596 £1M-£10M

Notice Dates

Publication Date
15 Aug 20242 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
19 Jul 20242 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
1
Supplier Name

Takeda UK Limited

Further Information

Notice Documents

  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG512134
    Enzyme Replacement Therapy Medicines - Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland: - NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV(r)) - NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase(r)) - NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal(r))

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...